Fibrolamellar liver cancer: the modern concept
Fibrolamellar hepatocellular carcinoma (FLC) is a relatively rare primary liver tumor of unknown etiology (chronic infections with hepatitis B or C viruses, chronic alcohol poisoning, cirrhosis of the liver), which occurs mainly in the young population. FLK is more often diagnosed already at common...
Main Authors: | E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5948 |
Similar Items
-
Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma
by: E. Yu. Antonova, et al.
Published: (2021-12-01) -
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
by: Kastenhuber ER, et al.
Published: (2019-01-01) -
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
by: Stefanie S. Schalm, et al.
Published: (2023-01-01) -
Fibrolamellar hepatocellular carcinoma: current clinical perspectives
by: Lafaro KJ, et al.
Published: (2015-10-01) -
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
by: Gummadi J, et al.
Published: (2023-05-01)